Intracardiac masses refer to abnormal growths or deposits within the chambers of the heart. These masses can vary widely in their composition and origin, ranging from benign tumors and blood clots to more serious conditions such as cancers. The presence of intracardiac masses can pose significant challenges to cardiac function, potentially affecting blood flow, leading to complications such as embolism or obstruction. Diagnostic techniques such as echocardiography and cardiac MRI play a crucial role in identifying and characterizing these masses, enabling healthcare professionals to determine the most appropriate course of treatment. Management strategies may involve medical therapies, surgical intervention, or a combination of approaches, depending on the nature and severity of the intracardiac mass. Timely detection and intervention are essential in addressing intracardiac masses and preserving overall cardiac health.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain